{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:08:50Z","timestamp":1790154530423,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11804-7","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:00:35Z","timestamp":1760601635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predisposing, enabling, and need factors influencing rapid uptake of the world health organization-endorsed TB diagnostic technologies in Africa"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-9775","authenticated-orcid":false,"given":"Jean de Dieu","family":"Iragena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Katamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandi","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Joloba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Ssengooba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"11804_CR1","unstructured":"WHO. Geneva: World Health Organization; 2016."},{"key":"11804_CR2","unstructured":"WHO. Global tuberculosis report 2023. Geneva: World Health Organization. 2023."},{"key":"11804_CR3","unstructured":"WHO. WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection. 2021 update ed. Geneva: World Health Organization. 2021."},{"issue":"9","key":"11804_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/hiv.12635","volume":"19","author":"J Hongler","year":"2018","unstructured":"Hongler J, Musaazi J, Ledergerber B, Eberhard N, Sekaggya-Wiltshire C, Keller PM, et al. Comparison of L\u00f6wenstein-jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV. HIV Med. 2018;19(9):654\u201361. https:\/\/doi.org\/10.1111\/hiv.12635.","journal-title":"HIV Med"},{"issue":"1","key":"11804_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/JCM.44.1.20-28.2006","volume":"44","author":"C Piersimoni","year":"2006","unstructured":"Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol. 2006;44(1):20\u20138.","journal-title":"J Clin Microbiol"},{"key":"11804_CR6","unstructured":"WHO. Global tuberculosis report 2013. World Health Organization. 2013."},{"issue":"1","key":"11804_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1186\/s12879-017-2898-3","volume":"17","author":"NE Maningi","year":"2017","unstructured":"Maningi NE, Malinga LA, Antiabong JF, Lekalakala RM, Mbelle NM. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. BMC Infect Dis. 2017;17(1):795. https:\/\/doi.org\/10.1186\/s12879-017-2898-3. Epub 20171228.","journal-title":"BMC Infect Dis"},{"key":"11804_CR8","unstructured":"WHO. Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement. World Health Organization. 2011."},{"issue":"9","key":"11804_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S1473-3099(06)70578-3","volume":"6","author":"KR Steingart","year":"2006","unstructured":"Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(9):570\u201381.","journal-title":"Lancet Infect Dis"},{"key":"11804_CR10","unstructured":"WHO. Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement. Geneva: World Health Organization. 2011."},{"issue":"2","key":"11804_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/0974-2727.105592","volume":"4","author":"S Singh","year":"2012","unstructured":"Singh S, Kumar P, Sharma S, Mumbowa F, Martin A, Durier N. Rapid identification and drug susceptibility testing of Mycobacterium tuberculosis: standard operating procedure for Non-Commercial assays: part 1: microscopic observation drug susceptibility assay v2.4.12. J Lab Physicians. 2012;4(2):101\u201311. PubMed PMID: 23440310; PubMed Central PMCID: PMCPMC3574494.","journal-title":"J Lab Physicians"},{"key":"11804_CR12","unstructured":"WHO. Policy Statement. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF System. Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF System. WHO Guidelines Approved by the Guidelines Review Committee. Geneva. 2011."},{"key":"11804_CR13","unstructured":"WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB (No. WHO\/HTM\/TB\/2013.16). World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update. WHO Guidelines Approved by the Guidelines Review Committee. Geneva2013."},{"issue":"1","key":"11804_CR14","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1038\/s41598-019-53086-5","volume":"9","author":"J Osei Sekyere","year":"2019","unstructured":"Osei Sekyere J, Maphalala N, Malinga LA, Mbelle NM, Maningi NE. A comparative evaluation of the new Genexpert MTB\/RIF ultra and other rapid diagnostic assays for detecting tuberculosis in pulmonary and extra pulmonary specimens. Sci Rep. 2019;9(1):16587. https:\/\/doi.org\/10.1038\/s41598-019-53086-5. Epub 20191112.","journal-title":"Sci Rep"},{"key":"11804_CR15","unstructured":"WHO. Use of Xpert MTB\/RIF and Xpert MTB\/RIF Ultra on GeneXpert 10-colour instruments: WHO policy statement. 2021."},{"issue":"8","key":"11804_CR16","doi-asserted-by":"publisher","first-page":"e0284545","DOI":"10.1371\/journal.pone.0284545","volume":"18","author":"A Katamba","year":"2023","unstructured":"Katamba A, Ssengooba W, Sserubiri J, Semugenze D, Kasule GW, Nyombi A, et al. Evaluation of Xpert MTB\/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda. PLoS ONE. 2023;18(8):e0284545. https:\/\/doi.org\/10.1371\/journal.pone.0284545. (Epub 20230817).","journal-title":"PLoS ONE"},{"key":"11804_CR17","unstructured":"WHO. The use of lateral flow urine Lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV: policy guidance (No. WHO\/HTM\/TB\/2015.25). World Health Organization. 2015."},{"key":"11804_CR18","unstructured":"WHO. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update 2019. Geneva: World Health Organization. 2019."},{"issue":"6","key":"11804_CR19","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1016\/S2214-109X(23)00135-3","volume":"11","author":"T Broger","year":"2023","unstructured":"Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc F-X, et al. Diagnostic yield of urine Lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Global Health. 2023;11(6):e903\u201316.","journal-title":"Lancet Global Health"},{"issue":"5","key":"11804_CR20","doi-asserted-by":"publisher","first-page":"e1003113","DOI":"10.1371\/journal.pmed.1003113","volume":"17","author":"T Broger","year":"2020","unstructured":"Broger T, Nicol MP, Sz\u00e9kely R, Bjerrum S, Sossen B, Schutz C, et al. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: a meta-analysis of individual in- and outpatient data. PLoS Med. 2020;17(5):e1003113. https:\/\/doi.org\/10.1371\/journal.pmed.1003113. (Epub 20200501).","journal-title":"PLoS Med"},{"issue":"4","key":"11804_CR21","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/S2214-109X","volume":"11","author":"AL Garcia-Basteiro","year":"2023","unstructured":"Garcia-Basteiro AL, Cobelens F, Ssengooba W, Theron G. Lots of considerations when evaluating the FujiLAM assay. Lancet Glob Health. 2023;11(4):e501. https:\/\/doi.org\/10.1016\/S2214-109X. (23)00114-6. PubMed PMID: 36925167.","journal-title":"Lancet Glob Health"},{"key":"11804_CR22","unstructured":"WHO. The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. The use of Loop-Mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. WHO Guidelines Approved by the Guidelines Review Committee. Geneva. 2016."},{"issue":"4","key":"11804_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/ijmr.IJMR_2539_19","volume":"152","author":"NS Gomathi","year":"2020","unstructured":"Gomathi NS, Singh M, Singh UB, Myneedu VP, Chauhan DS, Sarin R, et al. Multicentric validation of Indigenous molecular test truenat MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards. Indian J Med Res. 2020;152(4):378\u201385. .IJMR_2539_19. PubMed PMID: 33380702; PubMed Central PMCID: PMCPMC8061602.","journal-title":"Indian J Med Res"},{"key":"11804_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-021-01841-6","volume":"22","author":"AKJ Teo","year":"2021","unstructured":"Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respir Res. 2021;22:1\u201328.","journal-title":"Respir Res"},{"issue":"11","key":"11804_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jmoldx.2022.07.005","volume":"24","author":"FP Maurer","year":"2022","unstructured":"Maurer FP, Shubladze N, Kalmambetova G, Felker I, Kuchukhidze G, K\u00f6ser CU, et al. Diagnostic capacities for multidrug-resistant tuberculosis in the world health organization European region: action is needed by all member states. J Mol Diagn. 2022;24(11):1189\u201394. https:\/\/doi.org\/10.1016\/j.jmoldx.2022.07.005.","journal-title":"J Mol Diagn"},{"issue":"7","key":"11804_CR26","doi-asserted-by":"publisher","first-page":"e0255146","DOI":"10.1371\/journal.pone.0255146","volume":"16","author":"G Assefa","year":"2021","unstructured":"Assefa G, Desta K, Araya S, Girma S, Mihret A, Hailu T, et al. Diagnostic efficacy of Light-Emitting diode (LED) fluorescence based microscope for the diagnosis of tuberculous lymphadenitis. PLoS ONE. 2021;16(7):e0255146. https:\/\/doi.org\/10.1371\/journal.pone.0255146. PubMed PMID: rayyan-500705206.","journal-title":"PLoS ONE"},{"issue":"1","key":"11804_CR27","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.4102\/ajlm.v11i1.1811","volume":"11","author":"V Williams","year":"2022","unstructured":"Williams V, Calnan M, Edem B, Onwuchekwa C, Okoro C, Candari C, et al. GeneXpert rollout in three high-burden tuberculosis countries in africa: A review of pulmonary tuberculosis diagnosis and outcomes from 2001 to 2019. Afr J Lab Med. 2022;11(1):1811. https:\/\/doi.org\/10.4102\/ajlm.v11i1.1811. Epub 20220830.","journal-title":"Afr J Lab Med"},{"key":"11804_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.12688\/gatesopenres.13112.2","volume":"4","author":"DN Singhroy","year":"2020","unstructured":"Singhroy DN, MacLean E, Kohli M, Lessem E, Branigan D, England K, et al. Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV\/AIDS burden: current landscape and barriers. Gates Open Res. 2020;4:24. https:\/\/doi.org\/10.12688\/gatesopenres.13112.2. Epub 20200407.","journal-title":"Gates Open Res"},{"issue":"1","key":"11804_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12879-019-3881-y","volume":"19","author":"PB Shete","year":"2019","unstructured":"Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):268. https:\/\/doi.org\/10.1186\/s12879-019-3881-y. Epub 20190319.","journal-title":"BMC Infect Dis"},{"key":"11804_CR30","unstructured":"World Health Organization. Regional Office for A. Tuberculosis in the WHO African Region: 2023 progress update. Brazzaville: World Health Organization. Regional Office for Africa, 2023 2023. Report No.: Contract No.: WHO\/AFRO\/UCN:2023-04."},{"issue":"10315","key":"11804_CR31","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0140-6736(21)00673-5","volume":"398","author":"KA Fleming","year":"2021","unstructured":"Fleming KA, Horton S, Wilson ML, Atun R, DeStigter K, Flanigan J, et al. The lancet commission on diagnostics: transforming access to diagnostics. Lancet. 2021;398(10315):1997\u20132050. https:\/\/doi.org\/10.1016\/S0140-6736(21)00673-5.","journal-title":"Lancet"},{"issue":"10","key":"11804_CR32","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.5588\/ijtld.12.0391","volume":"16","author":"M Pai","year":"2012","unstructured":"Pai M, Palamountain K. New tuberculosis technologies: challenges for retooling and scale-up [State of the Art series. New tools. Number 4 in the series]. Int J Tuberc Lung Dis. 2012;16(10):1281\u201390.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"11804_CR33","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v6i2.490","volume":"6","author":"H Albert","year":"2017","unstructured":"Albert H, de Dieu Iragena J, Kao K, Erni D, Mekonen T, Onyebujoh PC. Implementation of quality management systems and progress towards accreditation of National tuberculosis reference laboratories in Africa. Afr J Lab Med. 2017;6(2):490. https:\/\/doi.org\/10.4102\/ajlm.v6i2.490.","journal-title":"Afr J Lab Med"},{"key":"11804_CR34","volume-title":"Strengthening public health laboratories in the WHO African region: a critical need for disease control: report of the regional director","author":"Regional Committee for A","year":"2008","unstructured":"Regional Committee for A. Strengthening public health laboratories in the WHO African region: a critical need for disease control: report of the regional director. Brazzaville: World Health Organization. Regional Office for Africa; 2008."},{"issue":"11","key":"11804_CR35","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/s1473-3099(18)30120-8","volume":"18","author":"JN Nkengasong","year":"2018","unstructured":"Nkengasong JN, Mbopi-Keou FX, Peeling RW, Yao K, Zeh CE, Schneidman M, et al. Laboratory medicine in Africa since 2008: then, now, and the future. Lancet Infect Dis. 2018;18(11):e362\u20137. https:\/\/doi.org\/10.1016\/s1473-3099(18)30120-8. Epub 20180703.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11804_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12960-023-00876-8","volume":"21","author":"N Dorothy","year":"2023","unstructured":"Dorothy N, Niringiyimana B, Enock W, Guido O, Joel K, Isa A, et al. Evaluating the effectiveness of uganda\u2019s supranational TB reference laboratory quality management system training program. Hum Resour Health. 2023;21(1):89. https:\/\/doi.org\/10.1186\/s12960-023-00876-8. Epub 20231121.","journal-title":"Hum Resour Health"},{"key":"11804_CR37","volume-title":"Rapid implementation of the Xpert MTB\/RIF diagnostic test: technical and operational \u2018How-to\u2019; practical considerations","author":"WHO","year":"2011","unstructured":"WHO. Rapid implementation of the Xpert MTB\/RIF diagnostic test: technical and operational \u2018How-to\u2019; practical considerations. Geneva: World Health Organization; 2011."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11804-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11804-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11804-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:00:43Z","timestamp":1760601643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11804-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11804"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11804-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval was obtained from the Research and Ethics Committee of the School of Biomedical Sciences (SBS-2022-154) at the College of Health Sciences, Makerere University, Kampala, Uganda, and from the Uganda National Council for Science and Technology (HS2393ES). In addition, participants were requested to consent by agreeing to participate in the data collection from the online survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The first author works for the World Health Organization (WHO). The contents of this article are the author\u2019s opinion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None declared.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"1342"}}